News

Advancing the Standard of Care

Stay up to date with the latest news, clinical breakthroughs, events, and industry developments.

Topic

Care Setting

    News

    FDA Grants De Novo Marketing Authorization to First-of-its-Kind Device for Objectively Assessing Patients at Risk of Pressure Ulcers

    June 26, 2020

    Bruin Biometrics, LLC (‚ÄúBBI‚Äù) has been granted U.S. Food and Drug Administration (FDA) marketing authorization for the SEM Scanner, a wireless handheld device that is indicated for use as an adjunct to the standard of care when assessing patients who are at increased risk for pressure ulcers. BBI's SEM Scanner Challenge's Everything We Know About…

    News

    BBI Wins Health Service Journal’s 2018 Best Innovation in Medical Technology Award

    June 26, 2020

    SEM Scanner Also Named 2018 Most Innovative Product by Journal of Wound Care The Health Service Journal has named Bruin Biometrics, LLC ("BBI"), as the winner of its 2018 Best Innovation in Medical Technology Award for developing the SEM Scanner device for the early risk assessment of pressure ulcers (also known as "bed sore"" or…

    News

    Bruin Biometrics, LLC Awarded CE Mark for the SEM Scanner, an Innovative Diagnostic Tool to Detect Pressure Induced Tissue Damage

    June 26, 2020

    The SEM Scanner has been CE mark approved in the European Union. The SEM Scanner is a Class IIa medical device that measures localized tissue oedema and pressure-induced tissue damage before damage can be seen at the skin's surface. BBI is finalizing plans for the initial commercial launch of the SEM Scanner in Europe. Bruin…